Skip to the page

Data / Form D filings / Cytodyme, Inc.

Cytodyme, Inc.: Form D filing

Cytodyme, Inc., a company in San Diego, CA, filed a Form D with the SEC in 2026. The latest, on February 9, 2026, reports $75,000 sold of a $2.5 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
10476 NEWBLISS WAY, San Diego, CA, 92126
Phone
(714) 928-0649
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2108897

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 9, 2026New notice$2,500,000$75,000$2,425,0003Jan 13, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Dennis WhiteExecutive Officer, Director
Tammy OgdenExecutive Officer, Director
Stephen Brown-BourneExecutive Officer, Director

Other companies in California that filed recently

Every Form D from the week of Feb 9, 2026 · All recent filings in California · All recent Other filings

Read from SEC EDGAR. Amount sold is what Cytodyme, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.